<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35486576</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.</ArticleTitle><Pagination><StartPage>e1010469</StartPage><MedlinePgn>e1010469</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1010469</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1010469</ELocationID><Abstract><AbstractText>Dengue virus (DENV) which infects about 390 million people per year in tropical and subtropical areas manifests various disease symptoms, ranging from fever to life-threatening hemorrhage and even shock. To date, there is still no effective treatment for DENV disease, but only supportive care. DENV nonstructural protein 1 (NS1) has been shown to play a key role in disease pathogenesis. Recent studies have shown that anti-DENV NS1 antibody can provide disease protection by blocking the DENV-induced disruption of endothelial integrity. We previously demonstrated that anti-NS1 monoclonal antibody (mAb) protected mice from all four serotypes of DENV challenge. Here, we generated humanized anti-NS1 mAbs and transferred them to mice after DENV infection. The results showed that DENV-induced prolonged bleeding time and skin hemorrhage were reduced, even several days after DENV challenge. Mechanistic studies showed the ability of humanized anti-NS1 mAbs to inhibit NS1-induced vascular hyperpermeability and to elicit Fc&#x3b3;-dependent complement-mediated cytolysis as well as antibody-dependent cellular cytotoxicity of cells infected with four serotypes of DENV. These results highlight humanized anti-NS1 mAb as a potential therapeutic agent in DENV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tien</LastName><ForeName>Sen-Mao</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Po-Chun</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leadgene Biomedical, Inc. Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yen-Chung</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Leadgene Biomedical, Inc. Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Yung-Chun</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0002-4797-8685</Identifier><AffiliationInfo><Affiliation>Leadgene Biomedical, Inc. Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chin-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>SIDSCO Biomedical Co., Ltd. Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Yu-San</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0003-2571-853X</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hong-Jyun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Yu-Peng</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hsing-Han</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SIDSCO Biomedical Co., Ltd. Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Chien-Chou</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Miao-Huei</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzong-Shiann</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0003-2951-6679</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Peng</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0002-0061-3478</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Shu-Fen</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Development Center for Biotechnology, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Che-Piao</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0003-3702-6602</Identifier><AffiliationInfo><Affiliation>Development Center for Biotechnology, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3561-7604</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Shu-Wen</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0002-6659-7992</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Trai-Ming</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-3172-7432</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="Y">Dengue Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35486576</ArticleId><ArticleId IdType="pmc">PMC9053773</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1010469</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-21-01501</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al.. The global distribution and burden of dengue. Nature. 2013;496(7446):504&#x2013;7. Epub 2013/04/09. doi: 10.1038/nature12060 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Screaton G, Mongkolsapaya J, Yacoub S, Roberts C. New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol. 2015;15(12):745&#x2013;59. Epub 2015/11/26. doi: 10.1038/nri3916 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3916</ArticleId><ArticleId IdType="pubmed">26603900</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Pierson TC. Molecular insight into dengue virus pathogenesis and its implications for disease control. Cell. 2015;162(3):488&#x2013;92. Epub 2015/08/02. doi: 10.1016/j.cell.2015.07.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.005</ArticleId><ArticleId IdType="pmc">PMC4522276</ArticleId><ArticleId IdType="pubmed">26232221</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzelnick LC, Coloma J, Harris E. Dengue: knowledge gaps, unmet needs, and research priorities. Lancet Infect Dis. 2017;17(3):e88&#x2013;e100. Epub 2017/02/12. doi: 10.1016/S1473-3099(16)30473-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)30473-X</ArticleId><ArticleId IdType="pmc">PMC5967882</ArticleId><ArticleId IdType="pubmed">28185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HR, Lai YC, Yeh TM. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate. J Biomed Sci. 2018;25(1):58. Epub 2018/07/25. doi: 10.1186/s12929-018-0462-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-018-0462-0</ArticleId><ArticleId IdType="pmc">PMC6057007</ArticleId><ArticleId IdType="pubmed">30037331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KR, Ong EZ, Ooi EE. Therapeutic antibodies as a treatment option for dengue fever. Expert Rev Anti Infect Ther. 2013;11(11):1147&#x2013;57. Epub 2013/10/08. doi: 10.1586/14787210.2013.839941 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2013.839941</ArticleId><ArticleId IdType="pubmed">24093625</ArticleId></ArticleIdList></Reference><Reference><Citation>de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, et al.. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A. 2012;109(19):7439&#x2013;44. Epub 2012/04/14. doi: 10.1073/pnas.1200566109 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1200566109</ArticleId><ArticleId IdType="pmc">PMC3358852</ArticleId><ArticleId IdType="pubmed">22499787</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, et al.. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015;16(2):170&#x2013;7. Epub 2014/12/17. doi: 10.1038/ni.3058 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3058</ArticleId><ArticleId IdType="pmc">PMC4445969</ArticleId><ArticleId IdType="pubmed">25501631</ArticleId></ArticleIdList></Reference><Reference><Citation>Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, et al.. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun. 2015;6:6341. Epub 2015/02/24. doi: 10.1038/ncomms7341 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7341</ArticleId><ArticleId IdType="pmc">PMC4346626</ArticleId><ArticleId IdType="pubmed">25698059</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Harris E. Dengue. Lancet. 2015;385(9966):453&#x2013;65. Epub 2014/09/19. doi: 10.1016/S0140-6736(14)60572-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60572-9</ArticleId><ArticleId IdType="pubmed">25230594</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, et al.. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017;358(6365):929&#x2013;32. Epub 2017/11/04. doi: 10.1126/science.aan6836 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan6836</ArticleId><ArticleId IdType="pmc">PMC5858873</ArticleId><ArticleId IdType="pubmed">29097492</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, et al.. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010;8(3):271&#x2013;83. Epub 2010/09/14. doi: 10.1016/j.chom.2010.08.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC3884547</ArticleId><ArticleId IdType="pubmed">20833378</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O&#x2019;Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146(1):201&#x2013;17. Epub 1977/07/01. doi: 10.1084/jem.146.1.201 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.146.1.201</ArticleId><ArticleId IdType="pmc">PMC2180729</ArticleId><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering SB, Akey DL, Wong MP, Brown WC, Lo NTN, Puerta-Guardo H, et al.. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction. Science. 2021;371(6525):194&#x2013;200. Epub 2021/01/09. doi: 10.1126/science.abc0476 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc0476</ArticleId><ArticleId IdType="pmc">PMC8000976</ArticleId><ArticleId IdType="pubmed">33414220</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N, Song H, Liu L, Bletchly C, Brillault L, Amarilla AA, et al.. A broadly protective antibody that targets the flavivirus NS1 protein. Science. 2021;371(6525):190&#x2013;4. Epub 2021/01/09. doi: 10.1126/science.abb9425 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9425</ArticleId><ArticleId IdType="pubmed">33414219</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Identifying protective dengue vaccines: guide to mastering an empirical process. Vaccine. 2013;31(41):4501&#x2013;7. Epub 2013/07/31. doi: 10.1016/j.vaccine.2013.06.079 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.06.079</ArticleId><ArticleId IdType="pubmed">23896423</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner DR, Puerta-Guardo H, Beatty PR, Harris E. The good, the bad, and the shocking: The multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis. Annu Rev Virol. 2018;5(1):227&#x2013;53. Epub 2018/07/26. doi: 10.1146/annurev-virology-101416-041848 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-101416-041848</ArticleId><ArticleId IdType="pmc">PMC6311996</ArticleId><ArticleId IdType="pubmed">30044715</ArticleId></ArticleIdList></Reference><Reference><Citation>Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, Deubel V. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol. 1999;73(7):6104&#x2013;10. Epub 1999/06/11. doi: 10.1128/JVI.73.7.6104-6110.1999 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.7.6104-6110.1999</ArticleId><ArticleId IdType="pmc">PMC112675</ArticleId><ArticleId IdType="pubmed">10364366</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DA, Young PR. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 2013;98(2):192&#x2013;208. Epub 2013/03/26. doi: 10.1016/j.antiviral.2013.03.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.008</ArticleId><ArticleId IdType="pubmed">23523765</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al.. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186(8):1165&#x2013;8. Epub 2002/10/02. doi: 10.1086/343813 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/343813</ArticleId><ArticleId IdType="pubmed">12355369</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige GN, Ogg GS. Pathogenesis of vascular leak in dengue virus infection. Immunology. 2017;151(3):261&#x2013;9. Epub 2017/04/25. doi: 10.1111/imm.12748 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12748</ArticleId><ArticleId IdType="pmc">PMC5461104</ArticleId><ArticleId IdType="pubmed">28437586</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaturro P, Cortese M, Chatel-Chaix L, Fischl W, Bartenschlager R. Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLoS Pathog. 2015;11(11):e1005277. Epub 2015/11/13. doi: 10.1371/journal.ppat.1005277 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005277</ArticleId><ArticleId IdType="pmc">PMC4643051</ArticleId><ArticleId IdType="pubmed">26562291</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutsche I, Coulibaly F, Voss JE, Salmon J, d&#x2019;Alayer J, Ermonval M, et al.. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc Natl Acad Sci U S A. 2011;108(19):8003&#x2013;8. Epub 2011/04/27. doi: 10.1073/pnas.1017338108 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017338108</ArticleId><ArticleId IdType="pmc">PMC3093454</ArticleId><ArticleId IdType="pubmed">21518917</ArticleId></ArticleIdList></Reference><Reference><Citation>Paranavitane SA, Gomes L, Kamaladasa A, Adikari TN, Wickramasinghe N, Jeewandara C, et al.. Dengue NS1 antigen as a marker of severe clinical disease. BMC Infect Dis. 2014;14:570. Epub 2014/11/05. doi: 10.1186/s12879-014-0570-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-014-0570-8</ArticleId><ArticleId IdType="pmc">PMC4222370</ArticleId><ArticleId IdType="pubmed">25366086</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, Harris E. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med. 2015;7(304):304ra141. Epub 2015/09/12. doi: 10.1126/scitranslmed.aaa3787 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3787</ArticleId><ArticleId IdType="pubmed">26355030</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N, Watterson D, Muller DA, Panetta AK, Sester DP, Liu L, et al.. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med. 2015;7(304):304ra142. Epub 2015/09/12. doi: 10.1126/scitranslmed.aaa3863 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3863</ArticleId><ArticleId IdType="pubmed">26355031</ArticleId></ArticleIdList></Reference><Reference><Citation>Puerta-Guardo H, Glasner DR, Harris E. Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog. 2016;12(7):e1005738. Epub 2016/07/16. doi: 10.1371/journal.ppat.1005738 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005738</ArticleId><ArticleId IdType="pmc">PMC4944995</ArticleId><ArticleId IdType="pubmed">27416066</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HR, Chao CH, Liu CC, Ho TS, Tsai HP, Perng GC, et al.. Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability. PLoS Pathog. 2018;14(4):e1007033. Epub 2018/04/28. doi: 10.1371/journal.ppat.1007033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007033</ArticleId><ArticleId IdType="pmc">PMC6044858</ArticleId><ArticleId IdType="pubmed">29702687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HR, Chuang YC, Lin YS, Liu HS, Liu CC, Perng GC, et al.. Dengue virus nonstructural protein 1 induces vascular leakage through macrophage migration inhibitory factor and autophagy. PLoS Negl Trop Dis. 2016;10(7):e0004828. Epub 2016/07/15. doi: 10.1371/journal.pntd.0004828 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004828</ArticleId><ArticleId IdType="pmc">PMC4943727</ArticleId><ArticleId IdType="pubmed">27409803</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N, Watterson D, Blumenthal A, Baxter AG, Young PR, Stacey KJ. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. Immunol Cell Biol. 2017;95(5):491&#x2013;5. Epub 2017/02/22. doi: 10.1038/icb.2017.5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2017.5</ArticleId><ArticleId IdType="pubmed">28220810</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner DR, Ratnasiri K, Puerta-Guardo H, Espinosa DA, Beatty PR, Harris E. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. PLoS Pathog. 2017;13(11):e1006673. Epub 2017/11/10. doi: 10.1371/journal.ppat.1006673 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006673</ArticleId><ArticleId IdType="pmc">PMC5679539</ArticleId><ArticleId IdType="pubmed">29121099</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CH, Wu WC, Lai YC, Tsai PJ, Perng GC, Lin YS, et al.. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathog. 2019;15(4):e1007625. Epub 2019/04/23. doi: 10.1371/journal.ppat.1007625 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007625</ArticleId><ArticleId IdType="pmc">PMC6497319</ArticleId><ArticleId IdType="pubmed">31009511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Ng MM, Chu JJ. Activation of TLR2 and TLR6 by dengue NS1 protein and its implications in the immunopathogenesis of dengue virus infection. PLoS Pathog. 2015;11(7):e1005053. Epub 2015/08/01. doi: 10.1371/journal.ppat.1005053 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005053</ArticleId><ArticleId IdType="pmc">PMC4520596</ArticleId><ArticleId IdType="pubmed">26226614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Lu YT, Huang CH, Lin CF, Anderson R, Liu HS, et al.. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1. PLoS One. 2014;9(3):e92495. Epub 2014/03/25. doi: 10.1371/journal.pone.0092495 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092495</ArticleId><ArticleId IdType="pmc">PMC3962419</ArticleId><ArticleId IdType="pubmed">24658118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Chen PW, Chen CY, Lai YC, Chu YT, Hung CY, et al.. Therapeutic effects of monoclonal antibody against dengue virus NS1 in a STAT1 knockout mouse model of dengue infection. J Immunol. 2017;199(8):2834&#x2013;44. Epub 2017/09/15. doi: 10.4049/jimmunol.1601523 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601523</ArticleId><ArticleId IdType="pubmed">28904127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YC, Chuang YC, Liu CC, Ho TS, Lin YS, Anderson R, et al.. Antibodies against modified NS1 wing domain peptide protect against dengue virus infection. Sci Rep. 2017;7(1):6975. Epub 2017/08/03. doi: 10.1038/s41598-017-07308-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07308-3</ArticleId><ArticleId IdType="pmc">PMC5539099</ArticleId><ArticleId IdType="pubmed">28765561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol. 2007;81(11):5518&#x2013;26. Epub 2007/03/16. doi: 10.1128/JVI.02575-06 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02575-06</ArticleId><ArticleId IdType="pmc">PMC1900309</ArticleId><ArticleId IdType="pubmed">17360740</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu-Hsieh BA, Yen YT, Chen HC. Dengue hemorrhage in a mouse model. Ann N Y Acad Sci. 2009;1171 Suppl 1:E42&#x2013;7. Epub 2009/09/16. doi: 10.1111/j.1749-6632.2009.05053.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.05053.x</ArticleId><ArticleId IdType="pubmed">19751401</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen YT, Chen HC, Lin YD, Shieh CC, Wu-Hsieh BA. Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol. 2008;82(24):12312&#x2013;24. Epub 2008/10/10. doi: 10.1128/JVI.00968-08 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00968-08</ArticleId><ArticleId IdType="pmc">PMC2593312</ArticleId><ArticleId IdType="pubmed">18842737</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo M, Kim HS, Tong RK, Bainbridge TW, Vernes JM, Zhang Y, et al.. Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice. J Biol Chem. 2017;292(9):3900&#x2013;8. Epub 2017/01/13. doi: 10.1074/jbc.M116.767749 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.767749</ArticleId><ArticleId IdType="pmc">PMC5339770</ArticleId><ArticleId IdType="pubmed">28077575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey MJ, Duehr J, Dulin H, Broecker F, Brown JA, Arumemi FO, et al.. Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model. Nat Commun. 2018;9(1):4560. Epub 2018/11/06. doi: 10.1038/s41467-018-07008-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07008-0</ArticleId><ArticleId IdType="pmc">PMC6212565</ArticleId><ArticleId IdType="pubmed">30385750</ArticleId></ArticleIdList></Reference><Reference><Citation>Block OK, Rodrigo WW, Quinn M, Jin X, Rose RC, Schlesinger JJ. A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice. Vaccine. 2010;28(51):8085&#x2013;94. Epub 2010/10/21. doi: 10.1016/j.vaccine.2010.10.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.10.004</ArticleId><ArticleId IdType="pubmed">20959154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SW, Chuang YC, Lin YS, Lei HY, Liu HS, Yeh TM. Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. J Infect. 2012;64(3):325&#x2013;34. Epub 2011/12/06. doi: 10.1016/j.jinf.2011.11.023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2011.11.023</ArticleId><ArticleId IdType="pubmed">22138554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PX, Ting DHR, Boey CPH, Tan ETX, Chia JZH, Idris F, et al.. Relative contribution of nonstructural protein 1 in dengue pathogenesis. J Exp Med. 2020;217(9). Epub 2020/06/26. doi: 10.1084/jem.20191548 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191548</ArticleId><ArticleId IdType="pmc">PMC7478733</ArticleId><ArticleId IdType="pubmed">32584412</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz T, Beatty PR, MacMillen Z, Killingbeck SS, Wang C, Harris E. Antibody epitopes identified in critical regions of dengue virus nonstructural 1 protein in mouse vaccination and natural human infections. J Immunol. 2017;198(10):4025&#x2013;35. Epub 2017/04/07. doi: 10.4049/jimmunol.1700029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700029</ArticleId><ArticleId IdType="pmc">PMC5603231</ArticleId><ArticleId IdType="pubmed">28381638</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayathilaka D, Gomes L, Jeewandara C, Jayarathna GSB, Herath D, Perera PA, et al.. Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection. Nat Commun. 2018;9(1):5242. Epub 2018/12/12. doi: 10.1038/s41467-018-07667-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07667-z</ArticleId><ArticleId IdType="pmc">PMC6286345</ArticleId><ArticleId IdType="pubmed">30531923</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconar AK. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol. 1997;142(5):897&#x2013;916. Epub 1997/01/01. doi: 10.1007/s007050050127 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007050050127</ArticleId><ArticleId IdType="pubmed">9191856</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Lei HY, Lin YS, Liu HS, Wu HL, Yeh TM. Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. J Immunol. 2011;187(12):6483&#x2013;90. Epub 2011/11/15. doi: 10.4049/jimmunol.1102218 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102218</ArticleId><ArticleId IdType="pubmed">22079981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, et al.. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol. 2001;63(2):143&#x2013;9. Epub 2001/02/15. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11170051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, et al.. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol. 2003;69(1):82&#x2013;90. Epub 2002/11/19. doi: 10.1002/jmv.10261 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10261</ArticleId><ArticleId IdType="pubmed">12436482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, Shiau AL, et al.. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol. 2005;174(1):395&#x2013;403. Epub 2004/12/22. doi: 10.4049/jimmunol.174.1.395 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.1.395</ArticleId><ArticleId IdType="pubmed">15611263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK, et al.. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med (Maywood). 2011;236(5):515&#x2013;23. Epub 2011/04/20. doi: 10.1258/ebm.2011.010339 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2011.010339</ArticleId><ArticleId IdType="pubmed">21502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HJ, Lin CF, Lei HY, Liu HS, Yeh TM, Luo YH, et al.. Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Exp Biol Med (Maywood). 2009;234(1):63&#x2013;73. Epub 2008/11/11. doi: 10.3181/0805-RM-147 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0805-RM-147</ArticleId><ArticleId IdType="pubmed">18997103</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, Yeh TM, et al.. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J Immunol. 2009;183(3):1797&#x2013;803. Epub 2009/07/14. doi: 10.4049/jimmunol.0800672 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0800672</ArticleId><ArticleId IdType="pubmed">19592650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, Williams M, Nagabhushana N, Jani V, Defang G, Morrison BJ. NK cells activated through antibody-dependent cell cytotoxicity and armed with degranulation/IFN-&#x3b3; production suppress antibody-dependent enhancement of dengue viral infection. Sci Rep. 2019;9(1):1109. Epub 2019/02/03. doi: 10.1038/s41598-018-36972-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36972-2</ArticleId><ArticleId IdType="pmc">PMC6358599</ArticleId><ArticleId IdType="pubmed">30710094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Hebblewaite D, Brandt WE, Ennis FA. Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol. 1984;52(1):223&#x2013;30. Epub 1984/10/01. doi: 10.1128/JVI.52.1.223-230.1984 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.52.1.223-230.1984</ArticleId><ArticleId IdType="pmc">PMC254509</ArticleId><ArticleId IdType="pubmed">6207308</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a G, Arango M, P&#xe9;rez AB, Fonte L, Sierra B, Rodr&#xed;guez-Roche R, et al.. Antibodies from patients with dengue viral infection mediate cellular cytotoxicity. J Clin Virol. 2006;37(1):53&#x2013;7. Epub 2006/06/22. doi: 10.1016/j.jcv.2006.04.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.04.010</ArticleId><ArticleId IdType="pubmed">16787760</ArticleId></ArticleIdList></Reference><Reference><Citation>Puerta-Guardo H, Glasner DR, Espinosa DA, Biering SB, Patana M, Ratnasiri K, et al.. Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism. Cell Rep. 2019;26(6):1598&#x2013;613.e8. Epub 2019/02/07. doi: 10.1016/j.celrep.2019.01.036 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.036</ArticleId><ArticleId IdType="pmc">PMC6934102</ArticleId><ArticleId IdType="pubmed">30726741</ArticleId></ArticleIdList></Reference><Reference><Citation>Puerta-Guardo H, Tabata T, Petitt M, Dimitrova M, Glasner DR, Pereira L, et al.. Zika virus nonstructural protein 1 disrupts glycosaminoglycans and causes permeability in developing human placentas. J Infect Dis. 2020;221(2):313&#x2013;24. Epub 2019/06/30. doi: 10.1093/infdis/jiz331 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz331</ArticleId><ArticleId IdType="pmc">PMC6936002</ArticleId><ArticleId IdType="pubmed">31250000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradbury ARM, Trinklein ND, Thie H, Wilkinson IC, Tandon AK, Anderson S, et al.. When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions. MAbs. 2018;10(4):539&#x2013;46. Epub 2018/02/28. doi: 10.1080/19420862.2018.1445456 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19420862.2018.1445456</ArticleId><ArticleId IdType="pmc">PMC5973764</ArticleId><ArticleId IdType="pubmed">29485921</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena A, Wu D. Advances in therapeutic Fc engineering&#x2014;Modulation of IgG-associated effector functions and serum half-life. Front Immunol. 2016;7:580. Epub 2016/12/27. doi: 10.3389/fimmu.2016.00580 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00580</ArticleId><ArticleId IdType="pmc">PMC5149539</ArticleId><ArticleId IdType="pubmed">28018347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Mathieu M, Brezski RJ. IgG Fc engineering to modulate antibody effector functions. Protein Cell. 2018;9(1):63&#x2013;73. Epub 2017/10/08. doi: 10.1007/s13238-017-0473-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0473-8</ArticleId><ArticleId IdType="pmc">PMC5777978</ArticleId><ArticleId IdType="pubmed">28986820</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang XN, Berman AE, Swanson RA, Yenari MA. Digitally quantifying cerebral hemorrhage using Photoshop and Image J. J Neurosci Methods. 2010;190(2):240&#x2013;3. Epub 2010/05/11. doi: 10.1016/j.jneumeth.2010.05.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2010.05.004</ArticleId><ArticleId IdType="pmc">PMC2898728</ArticleId><ArticleId IdType="pubmed">20452374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>